Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes

Exp Neurol. 2017 Dec;298(Pt B):191-201. doi: 10.1016/j.expneurol.2017.04.008. Epub 2017 Apr 23.

Abstract

Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the progressive loss of dopaminergic (DA) neurons. Most PD cases are sporadic; however, rare familial forms have been identified. Autosomal recessive PD (ARPD) results from mutations in Parkin, PINK1, DJ-1, and ATP13A2, while rare, atypical juvenile ARPD result from mutations in FBXO7, DNAJC6, SYNJ1, and PLA2G6. Studying these genes and their function has revealed mitochondrial quality control, protein degradation processes, and oxidative stress responses as common pathways underlying PD pathogenesis. Understanding how aberrancy in these common processes leads to neurodegeneration has provided the field with numerous targets that may be therapeutically relevant to the development of disease-modifying treatments.

Keywords: Autosomal recessive Parkinson's disease; Mitochondria; Oxidative stress; PINK1; Parkin; Protein degradation.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dopaminergic Neurons / pathology
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • Mutation / genetics*
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism*
  • Parkinsonian Disorders / genetics*
  • Parkinsonian Disorders / pathology

Substances

  • Intracellular Signaling Peptides and Proteins